HUP0201904A3 - Inhibitors of lfa-1 binding to icams and uses thereof - Google Patents
Inhibitors of lfa-1 binding to icams and uses thereofInfo
- Publication number
- HUP0201904A3 HUP0201904A3 HU0201904A HUP0201904A HUP0201904A3 HU P0201904 A3 HUP0201904 A3 HU P0201904A3 HU 0201904 A HU0201904 A HU 0201904A HU P0201904 A HUP0201904 A HU P0201904A HU P0201904 A3 HUP0201904 A3 HU P0201904A3
- Authority
- HU
- Hungary
- Prior art keywords
- icams
- lfa
- inhibitors
- binding
- Prior art date
Links
- 101100341510 Mus musculus Itgal gene Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/33—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring
- C07C323/35—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring the thio group being a sulfide group
- C07C323/37—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring the thio group being a sulfide group the sulfur atom of the sulfide group being further bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/01—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton
- C07C323/09—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton having sulfur atoms of thio groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/70—Sulfur atoms
- C07D277/74—Sulfur atoms substituted by carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/90—Benzo [c] furans; Hydrogenated benzo [c] furans with an oxygen atom in position 1 and a nitrogen atom in position 3, or vice versa
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Control Of El Displays (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28532599A | 1999-04-02 | 1999-04-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0201904A2 HUP0201904A2 (en) | 2002-09-28 |
HUP0201904A3 true HUP0201904A3 (en) | 2003-04-28 |
Family
ID=23093752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0201904A HUP0201904A3 (en) | 1999-04-02 | 2000-04-03 | Inhibitors of lfa-1 binding to icams and uses thereof |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1165504A2 (ja) |
JP (1) | JP2002541141A (ja) |
KR (1) | KR20020003559A (ja) |
CN (2) | CN1351588A (ja) |
AU (2) | AU774054B2 (ja) |
BG (1) | BG106019A (ja) |
BR (1) | BR0009421A (ja) |
CA (1) | CA2369005A1 (ja) |
CZ (1) | CZ20013524A3 (ja) |
EA (1) | EA200101017A1 (ja) |
EE (1) | EE200100514A (ja) |
HR (1) | HRP20010777A2 (ja) |
HU (1) | HUP0201904A3 (ja) |
IL (1) | IL145528A0 (ja) |
IS (1) | IS6096A (ja) |
MX (1) | MXPA01009915A (ja) |
NO (1) | NO20014768L (ja) |
NZ (1) | NZ515238A (ja) |
PL (1) | PL351323A1 (ja) |
SK (1) | SK14022001A3 (ja) |
WO (1) | WO2000059878A2 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6515124B2 (en) * | 2000-02-09 | 2003-02-04 | Hoffman-La Roche Inc. | Dehydroamino acids |
AU6871801A (en) | 2000-06-29 | 2002-01-14 | Abbott Lab | Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
US7153944B2 (en) | 2000-07-31 | 2006-12-26 | The General Hospital Corporation | High affinity integrin polypeptides and uses thereof |
US7323552B2 (en) | 2000-07-31 | 2008-01-29 | The General Hospital Corporation | Variant integrin polypeptides and uses thereof |
US7064180B2 (en) | 2000-07-31 | 2006-06-20 | The General Hospital Corporation | High affinity integrin polypeptides and uses thereof |
AU2001286403A1 (en) * | 2000-07-31 | 2002-02-13 | The General Hospital Corporation | High affinity integrin polypeptides and uses thereof |
UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
CA2492035A1 (en) | 2002-07-11 | 2004-01-15 | Vicuron Pharmaceuticals, Inc. | N-hydroxyamide derivatives possessing antibacterial activity |
AU2004226838B8 (en) | 2003-04-04 | 2009-06-11 | H. Lundbeck A/S | 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors |
BRPI0417858B1 (pt) | 2003-12-23 | 2017-10-10 | H. Lundbeck A/S | Derivative compounds of aniline and pharmaceutical composition that understand it |
US7378448B2 (en) | 2004-03-15 | 2008-05-27 | Eli Lilly And Company | Diphenylether amide derivatives as opioid receptor antagonists |
AR052308A1 (es) | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
AR054393A1 (es) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
JP2007008877A (ja) * | 2005-06-30 | 2007-01-18 | Sato Pharmaceutical Co Ltd | 2−ピリドン誘導体を有効成分とする医薬組成物 |
BRPI0617423A2 (pt) * | 2005-10-18 | 2011-07-26 | Sigma Tau Ind Farmaceuti | inibidores de derivados de naftila da agregaÇço de beta-amilàides |
WO2010033655A1 (en) * | 2008-09-19 | 2010-03-25 | Complegen, Inc. | Compounds and methods for pkc theta inhibition |
US9884046B1 (en) * | 2017-06-26 | 2018-02-06 | Macau University Of Science And Technology | Method of treating lung cancer |
NL2026714B1 (en) | 2020-10-20 | 2022-06-16 | Lumicks Ca Holding B V | Improved detection of lymphocyte - target cell interaction |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1493728A1 (de) * | 1965-07-20 | 1969-08-28 | Lauterbach Dr Rudolf | Verfahren zur Herstellung von Aminophenylthioaethern |
US3576872A (en) * | 1968-05-03 | 1971-04-27 | Exxon Research Engineering Co | Herbicidal s-aryl arylamides |
DE2313721A1 (de) * | 1973-03-20 | 1974-10-03 | Bayer Ag | Neue 1-phenylsubstituierte 1,3,5triazine, verfahren zu ihrer herstellung, sowie ihre verwendung als arzneimittel |
GR73690B (ja) * | 1979-01-15 | 1984-04-02 | Celamerck Gmbh & Co Kg | |
US4973599A (en) * | 1989-03-14 | 1990-11-27 | Hoffman-La Roche Inc. | Phenylthioheterocyclic derivatives |
GB9403408D0 (en) * | 1994-02-23 | 1994-04-13 | Wellcome Found | Therapeutic benzonitriles |
TW530047B (en) | 1994-06-08 | 2003-05-01 | Pfizer | Corticotropin releasing factor antagonists |
US6110922A (en) * | 1998-12-29 | 2000-08-29 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
-
2000
- 2000-04-03 HU HU0201904A patent/HUP0201904A3/hu unknown
- 2000-04-03 CN CN00807734A patent/CN1351588A/zh active Pending
- 2000-04-03 CA CA002369005A patent/CA2369005A1/en not_active Abandoned
- 2000-04-03 KR KR1020017012479A patent/KR20020003559A/ko not_active Application Discontinuation
- 2000-04-03 AU AU41919/00A patent/AU774054B2/en not_active Ceased
- 2000-04-03 PL PL00351323A patent/PL351323A1/xx not_active Application Discontinuation
- 2000-04-03 CZ CZ20013524A patent/CZ20013524A3/cs unknown
- 2000-04-03 WO PCT/US2000/008840 patent/WO2000059878A2/en not_active Application Discontinuation
- 2000-04-03 MX MXPA01009915A patent/MXPA01009915A/es unknown
- 2000-04-03 SK SK1402-2001A patent/SK14022001A3/sk unknown
- 2000-04-03 EP EP00921626A patent/EP1165504A2/en not_active Withdrawn
- 2000-04-03 EA EA200101017A patent/EA200101017A1/ru unknown
- 2000-04-03 JP JP2000609391A patent/JP2002541141A/ja active Pending
- 2000-04-03 IL IL14552800A patent/IL145528A0/xx unknown
- 2000-04-03 CN CNA2005100794026A patent/CN1721401A/zh active Pending
- 2000-04-03 BR BR0009421-8A patent/BR0009421A/pt not_active Application Discontinuation
- 2000-04-03 EE EEP200100514A patent/EE200100514A/xx unknown
- 2000-04-03 NZ NZ515238A patent/NZ515238A/en unknown
-
2001
- 2001-09-28 IS IS6096A patent/IS6096A/is unknown
- 2001-10-01 NO NO20014768A patent/NO20014768L/no not_active Application Discontinuation
- 2001-10-16 BG BG106019A patent/BG106019A/xx unknown
- 2001-10-23 HR HR20010777A patent/HRP20010777A2/hr not_active Application Discontinuation
-
2004
- 2004-08-24 AU AU2004205210A patent/AU2004205210A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2004205210A1 (en) | 2004-09-23 |
SK14022001A3 (sk) | 2002-03-05 |
EE200100514A (et) | 2002-12-16 |
CN1721401A (zh) | 2006-01-18 |
NZ515238A (en) | 2005-02-25 |
CA2369005A1 (en) | 2000-10-12 |
EA200101017A1 (ru) | 2002-04-25 |
BR0009421A (pt) | 2002-03-26 |
EP1165504A2 (en) | 2002-01-02 |
NO20014768L (no) | 2001-11-29 |
BG106019A (en) | 2002-06-28 |
CN1351588A (zh) | 2002-05-29 |
AU4191900A (en) | 2000-10-23 |
WO2000059878A3 (en) | 2001-08-09 |
IL145528A0 (en) | 2002-06-30 |
AU774054B2 (en) | 2004-06-17 |
HUP0201904A2 (en) | 2002-09-28 |
NO20014768D0 (no) | 2001-10-01 |
WO2000059878A2 (en) | 2000-10-12 |
HRP20010777A2 (en) | 2002-12-31 |
MXPA01009915A (es) | 2003-08-20 |
CZ20013524A3 (cs) | 2002-06-12 |
KR20020003559A (ko) | 2002-01-12 |
IS6096A (is) | 2001-09-28 |
PL351323A1 (en) | 2003-04-07 |
JP2002541141A (ja) | 2002-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0201904A3 (en) | Inhibitors of lfa-1 binding to icams and uses thereof | |
GB0312806D0 (en) | Improvement in and relating to gratings | |
GB9911952D0 (en) | Improvements in and relating to gratings | |
HUP0202251A3 (en) | Heterocyclic containing biphenyl ap2 inhibitors and application | |
AU2018301A (en) | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases | |
HUP0102477A3 (en) | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases and pharmaceutical compositions containing the compounds | |
IL146530A0 (en) | Method of inhibiting neurotrophin-receptor binding | |
IL146529A0 (en) | Method of inhibiting neurotrophin-receptor binding | |
PL337645A1 (en) | Novel amidine derivatives and their application as thrombosin inhibitors | |
AU3671099A (en) | Methods and compositions pertaining to pd-loops | |
AU3669199A (en) | Methods of identifying and using hla binding compounds as hla-agonists and antagonists | |
AU7127600A (en) | Methods and compositions for modulating responsiveness to corticosteroids | |
AU4192000A (en) | Lfa-1 regulatory binding site and uses thereof | |
HUP0004058A3 (en) | Compositions and methods for reversibly increasing permeability of biomembranes | |
GB0001952D0 (en) | Improvements in and relating to wire binding machibes | |
EP1152057A4 (en) | ANTIBODIES BINDING TO THE TRYPSIN-LIKE ENZYME OF HUMAN AIRWAYS AND ITS USE | |
GB2347947B (en) | Improvements in and relating to guttering | |
AU3446600A (en) | Improvements in and relating to footwear | |
EP1071434A4 (en) | CNRE BINDING FACTORS AND THEIR USE | |
SI1309589T1 (sl) | Secninske spojine in njihova uporaba | |
TW409674U (en) | Improved page edges of books | |
GB9914099D0 (en) | Improvements in and relating to medicalstents | |
AU7886800A (en) | Pack of cards | |
GB9900979D0 (en) | Improvements in and relating to access | |
AU2646600A (en) | Polypeptide capable of binding to mannose and uses therefor |